|
0
|
|
Total Intravenous vs Volatile Inhalational Anesthesia for Major Noncardiac Surgery: A Randomized Clinical Trial.
(jamanetwork.com)
|
Jhanji S
…
Yeung J
JAMA
2026-08-12
|
#anesthesia
#clinical trial
#surgery
#recovery
#postoperative
|
|
0
|
|
Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.
(linkinghub.elsevier.com)
|
Motzer RJ
…
Schmidinger M
The Lancet
2026-08-12
|
#renal cell carcinoma
#clinical trial
#immunotherapy
#oncology
#tyrosine-kinase-inhibitors
|
|
0
|
|
Phase 1, first-in-human, randomized, placebo-controlled, dose-escalating study to evaluate OVX033, a nucleocapsid-based SARS-CoV-2 candidate vaccine.
(academic.oup.com)
|
Launay O
…
Nicolas F
Journal of Infectious Diseases
2026-08-12
|
#covid-19
#vaccination
#immunogenicity
#clinical trial
#safety
|
|
0
|
|
IL-2 mutein-engrafted antibody MHS552 selectively expands functional regulatory T cells in nonclinical models and healthy participants.
(nature.com)
|
Radanovic I
…
Gabrysova L
Nature Communications
2026-08-12
|
#immunotherapy
#regulatory t cells
#autoimmune
#clinical trial
#interleukin-2
|
|
0
|
|
First-line PD-1/VEGF bispecific antibody plus chemotherapy in triple-negative breast cancer: a phase 2 trial.
(nature.com)
|
Shao X
…
Ouyang Q
Nature Medicine
2026-08-12
|
#clinical trial
#immunotherapy
#breast cancer
#chemotherapy
|
|
0
|
|
Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.
(linkinghub.elsevier.com)
|
Colson AE
…
Ogbuagu O
The Lancet
2026-08-12
|
#clinical trial
#hiv
#virological suppression
|